Campbell & CO Investment Adviser LLC Syndax Pharmaceuticals Inc Transaction History

Campbell & CO Investment Adviser LLC

  • $1.3 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$18.82 - $23.79 $623,374 - $787,996
33,123 New
33,123 $680,000
Q1 2020

Apr 29, 2020
SELL
$6.65 - $12.03 $298,172 - $539,401
-44,838 Closed
0 $0
Q4 2019

Jan 23, 2020
BUY
$5.43 - $9.22 $243,470 - $413,406
44,838 New
44,838 $394,000
Q3 2019

Oct 16, 2019
SELL
$7.47 - $10.76 $294,108 - $423,642
-39,372 Closed
0 $0
Q2 2019

Jul 10, 2019
BUY
$4.9 - $9.31 $192,922 - $366,553
39,372 New
39,372 $367,000

Others Institutions Holding SNDX

# of Institutions
227
Shares Held
88.3M
Call Options Held
1.01M
Put Options Held
692K
View Full List

About Syndax Pharmaceuticals Inc

SNDX Quotes by TradingView
  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $910M
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Campbell & CO Investment Adviser LLC Portfolio

Follow Campbell & CO Investment Adviser LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

News

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email